CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-072 Trial Yahoo! Finance By John Harbison|2017-02-20T07:28:20-08:00February 2, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-072 Trial Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
